Runx2 Regulates G Protein-coupled Signaling Pathways to Control Growth of Osteoblast Progenitors*

Runt-related transcription factor 2 (Runx2) controls lineage commitment, proliferation, and anabolic functions of osteoblasts as the subnuclear effector of multiple signaling axes (e.g. transforming growth factor-β/BMP-SMAD, SRC/YES-YAP, and GROUCHO/TLE). Runx2 levels oscillate during the osteoblast cell cycle with maximal levels in G1. Here we examined what functions and target genes of Runx2 control osteoblast growth. Forced expression of wild type Runx2 suppresses growth of Runx2-/- osteoprogenitors. Point mutants defective for binding to WW domain or SMAD proteins or the nuclear matrix retain this growth regulatory ability. Hence, key signaling pathways are dispensable for growth control by Runx2. However, mutants defective for DNA binding or C-terminal gene repression/activation functions do not block proliferation. Target gene analysis by Affymetrix expression profiling shows that the C terminus of Runx2 regulates genes involved in G protein-coupled receptor signaling (e.g. Rgs2, Rgs4, Rgs5, Rgs16, Gpr23, Gpr30, Gpr54, Gpr64, and Gna13). We further examined the function of two genes linked to cAMP signaling as follows: Gpr30 that is stimulated and Rgs2 that is down-regulated by Runx2. RNA interference of Gpr30 and forced expression of Rgs2 in each case inhibit osteoblast proliferation. Notwithstanding its growth-suppressive potential, our results surprisingly indicate that Runx2 may sensitize cAMP-related G protein-coupled receptor signaling by activating Gpr30 and repressing Rgs2 gene expression in osteoblasts to increase responsiveness to mitogenic signals.

[1]  G. Stein,et al.  p68 (Ddx5) interacts with Runx2 and regulates osteoblast differentiation , 2008, Journal of cellular biochemistry.

[2]  S. K. Zaidi,et al.  Structural Coupling of Smad and Runx2 for Execution of the BMP2 Osteogenic Signal* , 2008, Journal of Biological Chemistry.

[3]  B. Conklin,et al.  Osteoblast expression of an engineered Gs-coupled receptor dramatically increases bone mass , 2008, Proceedings of the National Academy of Sciences.

[4]  J. Westendorf,et al.  Histone Deacetylase 7 Associates With Runx2 and Represses Its Activity During Osteoblast Maturation in a Deacetylation‐Independent Manner , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[5]  T. Komori.  Regulation of bone development and maintenance by Runx2. , 2008, Frontiers in bioscience : a journal and virtual library.

[6]  S. K. Zaidi,et al.  Runx2 deficiency and defective subnuclear targeting bypass senescence to promote immortalization and tumorigenic potential , 2007, Proceedings of the National Academy of Sciences.

[7]  E. Rozengurt.  Mitogenic signaling pathways induced by G protein‐coupled receptors , 2007, Journal of cellular physiology.

[8]  A. Chagin,et al.  GPR30 estrogen receptor expression in the growth plate declines as puberty progresses. , 2007, The Journal of clinical endocrinology and metabolism.

[9]  K. Blyth,et al.  Runx2 disruption promotes immortalization and confers resistance to oncogene-induced senescence in primary murine fibroblasts. , 2007, Cancer research.

[10]  D. Notterman,et al.  Determination of Dual Effects of Parathyroid Hormone on Skeletal Gene Expression in Vivo by Microarray and Network Analysis* , 2007, Journal of Biological Chemistry.

[11]  G. Stein,et al.  Cell cycle related modulations in Runx2 protein levels are independent of lymphocyte enhancer-binding factor 1 (Lef1) in proliferating osteoblasts , 2007, Journal of Molecular Histology.

[12]  R. Jilka.  Molecular and cellular mechanisms of the anabolic effect of intermittent PTH. , 2007, Bone.

[13]  S. K. Zaidi,et al.  Nuclear microenvironments in biological control and cancer , 2007, Nature Reviews Cancer.

[14]  L. Scobie,et al.  Insertional mutagenesis reveals progression genes and checkpoints in MYC/Runx2 lymphomas. , 2007, Cancer research.

[15]  G. Stein,et al.  Mitotic control of RUNX2 phosphorylation by both CDK1/cyclin B kinase and PP1/PP2A phosphatase in osteoblastic cells , 2007, Journal of cellular biochemistry.

[16]  David S. Lapointe,et al.  Mitotic retention of gene expression patterns by the cell fate-determining transcription factor Runx2 , 2007, Proceedings of the National Academy of Sciences.

[17]  G. Stein,et al.  Reconstitution of Runx2/Cbfa1‐null cells identifies a requirement for BMP2 signaling through a Runx2 functional domain during osteoblast differentiation , 2007, Journal of cellular biochemistry.

[18]  L. Sklar,et al.  GPR30: A G protein-coupled receptor for estrogen , 2007, Molecular and Cellular Endocrinology.

[19]  S. K. Zaidi,et al.  Mitotic occupancy and lineage-specific transcriptional control of rRNA genes by Runx2 , 2007, Nature.

[20]  B. Komm,et al.  Wnt signaling and osteoblastogenesis , 2007, Reviews in Endocrine and Metabolic Disorders.

[21]  G. Stein,et al.  Regulatory roles of Runx2 in metastatic tumor and cancer cell interactions with bone , 2006, Cancer and Metastasis Reviews.

[22]  R. Behringer,et al.  Runx2 inhibits chondrocyte proliferation and hypertrophy through its expression in the perichondrium. , 2006, Genes & development.

[23]  S. Dixon,et al.  Up-regulation of Endogenous RGS2 Mediates Cross-desensitization between Gs and Gq Signaling in Osteoblasts* , 2006, Journal of Biological Chemistry.

[24]  C. Lengner,et al.  Networks and hubs for the transcriptional control of osteoblastogenesis , 2006, Reviews in Endocrine and Metabolic Disorders.

[25]  F. Liu,et al.  Cyclin D1-Cdk4 Induce Runx2 Ubiquitination and Degradation* , 2006, Journal of Biological Chemistry.

[26]  J. Devedjian,et al.  Runx2 regulates the expression of GNAS on SaOs-2 cells. , 2006, Bone.

[27]  Rakesh Kumar,et al.  Steering estrogen signals from the plasma membrane to the nucleus: Two sides of the coin , 2006, Journal of cellular physiology.

[28]  M. Glimcher,et al.  Regulation of Adult Bone Mass by the Zinc Finger Adapter Protein Schnurri-3 , 2006, Science.

[29]  H. Kronenberg.  PTHrP and Skeletal Development , 2006, Annals of the New York Academy of Sciences.

[30]  A. Passaniti,et al.  Cell Cycle-dependent Phosphorylation of the RUNX2 Transcription Factor by cdc2 Regulates Endothelial Cell Proliferation* , 2006, Journal of Biological Chemistry.

[31]  K. Blyth,et al.  Runx2 and MYC collaborate in lymphoma development by suppressing apoptotic and growth arrest pathways in vivo. , 2006, Cancer research.

[32]  J. Wozney,et al.  Dlx5 Specifically Regulates Runx2 Type II Expression by Binding to Homeodomain-response Elements in the Runx2 Distal Promoter* , 2005, Journal of Biological Chemistry.

[33]  Edward J. Filardo,et al.  GPR30: a seven-transmembrane-spanning estrogen receptor that triggers EGF release , 2005, Trends in Endocrinology & Metabolism.

[34]  L. Quarles,et al.  Osteoblast calcium‐sensing receptor has characteristics of ANF/7TM receptors , 2005, Journal of cellular biochemistry.

[35]  R. Derynck,et al.  Repression of Runx2 function by TGF‐β through recruitment of class II histone deacetylases by Smad3 , 2005, The EMBO journal.

[36]  P. Marie,et al.  A role for fibroblast growth factor receptor-2 in the altered osteoblast phenotype induced by Twist haploinsufficiency in the Saethre-Chotzen syndrome. , 2005, Human molecular genetics.

[37]  G. Stein,et al.  The Bone-specific Expression of Runx2 Oscillates during the Cell Cycle to Support a G1-related Antiproliferative Function in Osteoblasts* , 2005, Journal of Biological Chemistry.

[38]  Karen Blyth,et al.  The runx genes: gain or loss of function in cancer , 2005, Nature Reviews Cancer.

[39]  Eric R. Prossnitz,et al.  A Transmembrane Intracellular Estrogen Receptor Mediates Rapid Cell Signaling , 2005, Science.

[40]  David M. Thomas,et al.  Terminal osteoblast differentiation, mediated by runx2 and p27KIP1, is disrupted in osteosarcoma , 2004, The Journal of cell biology.

[41]  Shinichi Watanabe,et al.  17beta-estradiol stimulates the growth of human keratinocytes by inducing cyclin D2 expression. , 2004, The Journal of investigative dermatology.

[42]  M. Arthur,et al.  Regulation of Tissue Inhibitor of Metalloproteinase 1 Gene Transcription by RUNX1 and RUNX2* , 2004, Journal of Biological Chemistry.

[43]  G. Stein,et al.  Nomenclature for Runt-related (RUNX) proteins , 2004, Oncogene.

[44]  D. Riccardi,et al.  Ca2+ as an extracellular signal in bone. , 2004, Cell calcium.

[45]  S. K. Zaidi,et al.  Tyrosine phosphorylation controls Runx2‐mediated subnuclear targeting of YAP to repress transcription , 2004, The EMBO journal.

[46]  Benjamin M. Bolstad,et al.  affy - analysis of Affymetrix GeneChip data at the probe level , 2004, Bioinform..

[47]  P. Roberson,et al.  Proteasomal Degradation of Runx2 Shortens Parathyroid Hormone-induced Anti-apoptotic Signaling in Osteoblasts , 2003, Journal of Biological Chemistry.

[48]  Claire K. Inman,et al.  The Osteoblast Transcription Factor Runx2 Is Expressed in Mammary Epithelial Cells and Mediates osteopontin Expression* , 2003, Journal of Biological Chemistry.

[49]  P. Marie.  Fibroblast growth factor signaling controlling osteoblast differentiation. , 2003, Gene.

[50]  John A. Robinson,et al.  Cell growth regulatory role of Runx2 during proliferative expansion of preosteoblasts. , 2003, Cancer research.

[51]  Brendan H. Lee,et al.  Type X collagen gene regulation by Runx2 contributes directly to its hypertrophic chondrocyte–specific expression in vivo , 2003, The Journal of cell biology.

[52]  Di Chen,et al.  E3 Ubiquitin Ligase Smurf1 Mediates Core-binding Factor α1/Runx2 Degradation and Plays A Specific Role in Osteoblast Differentiation* , 2003, Journal of Biological Chemistry.

[53]  David S. Lapointe,et al.  Phenotype discovery by gene expression profiling: Mapping of biological processes linked to BMP‐2‐mediated osteoblast differentiation , 2003, Journal of cellular biochemistry.

[54]  G. Karsenty,et al.  Transcriptional Coactivation of Bone-Specific Transcription Factor Cbfa1 by TAZ , 2003, Molecular and Cellular Biology.

[55]  H. Ryoo,et al.  The Protein Kinase C Pathway Plays a Central Role in the Fibroblast Growth Factor-stimulated Expression and Transactivation Activity of Runx2* , 2003, The Journal of Biological Chemistry.

[56]  C. Rosen.  The cellular and clinical parameters of anabolic therapy for osteoporosis. , 2003, Critical reviews in eukaryotic gene expression.

[57]  S. K. Zaidi,et al.  Runx2 (Cbfa1, AML-3) Interacts with Histone Deacetylase 6 and Represses the p21CIP1/WAF1 Promoter , 2002, Molecular and Cellular Biology.

[58]  G. Stein,et al.  Transcription factors RUNX1/AML1 and RUNX2/Cbfa1 dynamically associate with stationary subnuclear domains , 2002, Journal of Cell Science.

[59]  K. Blyth,et al.  Enforced Expression of Runx2 Perturbs T Cell Development at a Stage Coincident with β-Selection1 , 2002, The Journal of Immunology.

[60]  N. Selvamurugan,et al.  Parathyroid hormone-dependent signaling pathways regulating genes in bone cells. , 2002, Gene.

[61]  K. Thirunavukkarasu,et al.  Analysis of regulator of G‐protein signaling‐2 (RGS‐2) expression and function in osteoblastic cells , 2002, Journal of cellular biochemistry.

[62]  K. Bland,et al.  Estrogen Action Via the G Protein-Coupled Receptor , GPR 30 : Stimulation of Adenylyl Cyclase and cAMP-Mediated Attenuation of the Epidermal Growth Factor Receptor-to-MAPK Signaling Axis , 2001 .

[63]  C. Albanese,et al.  TGFbeta and PTHrP control chondrocyte proliferation by activating cyclin D1 expression. , 2001, Molecular biology of the cell.

[64]  S. K. Zaidi,et al.  A specific targeting signal directs Runx2/Cbfa1 to subnuclear domains and contributes to transactivation of the osteocalcin gene. , 2001, Journal of cell science.

[65]  W. C. Forrester,et al.  The retinoblastoma protein acts as a transcriptional coactivator required for osteogenic differentiation. , 2001, Molecular cell.

[66]  J. Downing,et al.  A hematopoietic-specific transmembrane protein, Art-1, is possibly regulated by AML1. , 2001, Biochemical and biophysical research communications.

[67]  L. Donehower,et al.  The Integrin-linked Kinase Regulates the Cyclin D1 Gene through Glycogen Synthase Kinase 3β and cAMP-responsive Element-binding Protein-dependent Pathways* , 2000, The Journal of Biological Chemistry.

[68]  M. Osborne,et al.  Groucho/TLE/R-esp proteins associate with the nuclear matrix and repress RUNX (CBF(alpha)/AML/PEBP2(alpha)) dependent activation of tissue-specific gene transcription. , 2000, Journal of cell science.

[69]  N. Selvamurugan,et al.  Constitutive expression and regulation of collagenase-3 in human breast cancer cells. , 2000, Molecular cell biology research communications : MCBRC.

[70]  G. Stein,et al.  The cell cycle regulator p27kip1 contributes to growth and differentiation of osteoblasts. , 1999, Cancer research.

[71]  R. Weigel,et al.  Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer. , 1997, Genomics.

[72]  E. Baxter,et al.  Proviral insertions induce the expression of bone-specific isoforms of PEBP2alphaA (CBFA1): evidence for a new myc collaborating oncogene. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[73]  C. Molina,et al.  Cell cycle regulation of cyclin A gene expression by the cyclic AMP-responsive transcription factors CREB and CREM , 1995, Molecular and cellular biology.